275 related articles for article (PubMed ID: 19436109)
61. Zinc chelation decreases IFN-β-induced STAT1 upregulation and iNOS expression in RAW 264.7 macrophages.
Reiber C; Brieger A; Engelhardt G; Hebel S; Rink L; Haase H
J Trace Elem Med Biol; 2017 Dec; 44():76-82. PubMed ID: 28965604
[TBL] [Abstract][Full Text] [Related]
62. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection.
Döffinger R; Jouanguy E; Dupuis S; Fondanèche MC; Stephan JL; Emile JF; Lamhamedi-Cherradi S; Altare F; Pallier A; Barcenas-Morales G; Meinl E; Krause C; Pestka S; Schreiber RD; Novelli F; Casanova JL
J Infect Dis; 2000 Jan; 181(1):379-84. PubMed ID: 10608793
[TBL] [Abstract][Full Text] [Related]
63. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.
Mizoguchi Y; Tsumura M; Okada S; Hirata O; Minegishi S; Imai K; Hyakuna N; Muramatsu H; Kojima S; Ozaki Y; Imai T; Takeda S; Okazaki T; Ito T; Yasunaga S; Takihara Y; Bryant VL; Kong XF; Cypowyj S; Boisson-Dupuis S; Puel A; Casanova JL; Morio T; Kobayashi M
J Leukoc Biol; 2014 Apr; 95(4):667-76. PubMed ID: 24343863
[TBL] [Abstract][Full Text] [Related]
64. Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway.
Harvey R; McCaughan C; Wise LM; Mercer AA; Fleming SB
Virus Res; 2015 Oct; 208():180-8. PubMed ID: 26113305
[TBL] [Abstract][Full Text] [Related]
65. Correlation of class II transactivator with HLA-DR antigen and its implications.
Xu KL; Li H; Pan XY; Li ZY; Lu QX; Zhang Y; Zhu HH; DU B; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):147-51. PubMed ID: 17490542
[TBL] [Abstract][Full Text] [Related]
66. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
67. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
68. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.
Kato A; Kiyotani K; Kubota T; Yoshida T; Tashiro M; Nagai Y
J Virol; 2007 Apr; 81(7):3264-71. PubMed ID: 17215288
[TBL] [Abstract][Full Text] [Related]
69. A Translational Investigation of IFN-α and STAT1 Signaling in Endothelial Cells during Septic Shock Provides Therapeutic Perspectives.
Clere-Jehl R; Merdji H; Kassem M; Macquin C; De Cauwer A; Sibony A; Kurihara K; Minniti L; Abou Fayçal C; Bahram S; Meziani F; Helms J; Georgel P
Am J Respir Cell Mol Biol; 2021 Aug; 65(2):167-175. PubMed ID: 33798037
[TBL] [Abstract][Full Text] [Related]
70. VP8, the Major Tegument Protein of Bovine Herpesvirus 1, Interacts with Cellular STAT1 and Inhibits Interferon Beta Signaling.
Afroz S; Brownlie R; Fodje M; van Drunen Littel-van den Hurk S
J Virol; 2016 May; 90(10):4889-4904. PubMed ID: 26889034
[TBL] [Abstract][Full Text] [Related]
71. STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia.
Chen Z; Guo Z; Ma J; Liu F; Gao C; Liu S; Wang A; Wu R
Autoimmunity; 2015; 48(5):305-12. PubMed ID: 25707685
[TBL] [Abstract][Full Text] [Related]
72. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1.
Wong LH; Sim H; Chatterjee-Kishore M; Hatzinisiriou I; Devenish RJ; Stark G; Ralph SJ
J Biol Chem; 2002 May; 277(22):19408-17. PubMed ID: 11909852
[TBL] [Abstract][Full Text] [Related]
73. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes.
Dai X; Sayama K; Tohyama M; Shirakata Y; Yang L; Hirakawa S; Tokumaru S; Hashimoto K
Int Immunol; 2008 Jul; 20(7):901-9. PubMed ID: 18492658
[TBL] [Abstract][Full Text] [Related]
74. Fulminant Viral Hepatitis in Two Siblings with Inherited IL-10RB Deficiency.
Korol CB; Belkaya S; Alsohime F; Lorenzo L; Boisson-Dupuis S; Brancale J; Neehus AL; Vilarinho S; Zobaida A; Halwani R; Al-Muhsen S; Casanova JL; Jouanguy E
J Clin Immunol; 2023 Feb; 43(2):406-420. PubMed ID: 36308662
[TBL] [Abstract][Full Text] [Related]
75. A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.
Kong XF; Vogt G; Chapgier A; Lamaze C; Bustamante J; Prando C; Fortin A; Puel A; Feinberg J; Zhang XX; Gonnord P; Pihkala-Saarinen UM; Arola M; Moilanen P; Abel L; Korppi M; Boisson-Dupuis S; Casanova JL
Hum Mol Genet; 2010 Feb; 19(3):434-44. PubMed ID: 19880857
[TBL] [Abstract][Full Text] [Related]
76. The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic beta-cell apoptosis and its dysfunction in streptozotocin-treated mice.
Kim JY; Song EH; Lee S; Lim JH; Choi JS; Koh IU; Song J; Kim WH
Cell Signal; 2010 Nov; 22(11):1669-80. PubMed ID: 20600850
[TBL] [Abstract][Full Text] [Related]
77. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways.
Malmgaard L; Salazar-Mather TP; Lewis CA; Biron CA
J Virol; 2002 May; 76(9):4520-5. PubMed ID: 11932417
[TBL] [Abstract][Full Text] [Related]
78. Distinct requirements for IFNs and STAT1 in NK cell function.
Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
[TBL] [Abstract][Full Text] [Related]
79. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.
Wu M; Xu Y; Lin S; Zhang X; Xiang L; Yuan Z
J Gen Virol; 2007 Dec; 88(Pt 12):3260-3269. PubMed ID: 18024894
[TBL] [Abstract][Full Text] [Related]
80. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
